Source: Digestive Diseases and Sciences. Unidade: FMRP
Assunto: GASTROENTEROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTA, José Maurício S. C. et al. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences, v. 52, n. 1, p. 119-125, 2007Tradução . . Acesso em: 26 maio 2024.APA
Mota, J. M. S. C., Soares, P. M. G., Menezes, Á. A. J., Lemos, H. P., Cunha, F. de Q., Brito, G. A. C., et al. (2007). Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences, 52( 1), 119-125.NLM
Mota JMSC, Soares PMG, Menezes ÁAJ, Lemos HP, Cunha F de Q, Brito GAC, Ribeiro RA, Souza MHLP de. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences. 2007 ; 52( 1): 119-125.[citado 2024 maio 26 ]Vancouver
Mota JMSC, Soares PMG, Menezes ÁAJ, Lemos HP, Cunha F de Q, Brito GAC, Ribeiro RA, Souza MHLP de. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences. 2007 ; 52( 1): 119-125.[citado 2024 maio 26 ]
